Calamos Advisors’s BrightSpring Health Services BTSG Stock Holding History

Calamos Advisors’s Portfolio BTSG Stock Details BTSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.88M	Buy	+41,304	New	+$2.29M	0.01%	621

Other funds holding BTSG

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Calamos Advisors's BTSG Position: Q2 2026 in Review

Calamos Advisors opened a new position in BrightSpring Health Services (BTSG) in Q2 2026: 41,304 shares worth $2.88M. The stake represents 0.01% of the portfolio and ranks #621 among its holdings.

423 funds tracked by Wall St. Rank hold BTSG as of Q2 2026.

Calamos Advisors held 41,304 shares of BrightSpring Health Services worth $2.88M as of Q2 2026.
BrightSpring Health Services was a new Calamos Advisors position in Q2 2026.
BrightSpring Health Services made up 0.01% of Calamos Advisors's portfolio in Q2 2026, its #621 holding.
423 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.